LONDON, 07 October 2015 – OpenGamma, a financial technology company specializing in market structure risk management solutions, has enhanced its multi-CCP margining solution to support Eurex ETD, OTC, and Cross Margining. The Eurex Clearing Prisma Margin Estimator (PME), also announced today, is based on the OpenGamma Margining Eurex Clearing Module.
Better measurement and management of CCP exposures and associated costs is fast becoming a critical aspect of risk and capital management in the OTC derivatives market. The optimization of those costs through various mechanisms, whether through active collateral substitutions or capitalizing on available cross-margining benefits, is an important next step for the industry in a balance sheet-constrained world.
“We have been seeing increasing demand for better analytical capabilities across different CCP risk regimes due to regulatory pressures on balance sheets,” says Mas Nakachi, CEO of OpenGamma. “This is the latest example of how our software helps clients optimize their capital across all clearing venues and lines of business.”
“OpenGamma’s excellent platform provides both the transparency and flexibility for an easy-to-integrate service for fast margin analysis. The OpenGamma Eurex Clearing Module will help our clients to see the savings of our advanced margin methodology and thus the benefits of chosing Eurex Clearing,” explained Thomas Laux, Chief Risk Officer of Eurex Clearing.
OpenGamma is a new breed of financial technology firm whose guiding principle is to work with the derivatives industry in an open and collaborative manner to develop innovative technologies that address its increasingly complex needs.
OpenGamma helps financial services firms evaluate, understand, and manage market risk in an open, transparent manner.
The OpenGamma Platform enables firms to optimize their businesses in the evolving OTC markets, improving capital efficiency and balance sheet management. It provides tools for multi-CCP margin calculations, what‐if analysis and stress testing, and real‐time, cross-asset risk and trading analytics across customized risk scenarios and industry-standard metrics.
Used by both buy-side and sell-side firms, exchanges, CCPs, and other segments of the OTC derivatives market structure, OpenGamma brings a new standard of transparency to the industry, enabling users to gain more insight into their underlying risk exposures, better assess the true costs of trading, and respond more rapidly to the ever‐evolving regulatory landscape.
Backed by Accel Partners, FirstMark Capital, ICAP plc and Euclid Opportunities, OpenGamma is headquartered in London with an office in New York. For more information, visit http://www.opengamma.com.
Eurex Clearing is one of the leading central counterparties globally –assuring the safety and integrity of markets while providing innovation in risk management, clearing technology and client asset protection. Eurex Clearing provides fully-automated, straight-through post-trade services for derivatives, equities, bonds and secured funding & financing, as well as industry-leading risk management technologies.
With EurexOTC Clear for IRS, Eurex Clearing offers integrated clearing and collateralization of OTC trans-actions and exchange-traded derivatives under the umbrella of a single clearing house in a uniform legal framework covering all products. The OTC clearing service sets new standards in security and efficiency.
As part of Eurex Group, Eurex Clearing serves more than 190 clearing members in 16 countries, managing a collateral pool of around EUR 48 billion and processing gross risks valued approx. EUR 15.9 trillion every month.
Find out more at www.eurexclearing.com
Eurex Group is comprised of Eurex Exchange, the International Securities Exchange (ISE), the European Energy Exchange (EEX), Eurex Clearing, Eurex Bonds and Eurex Repo.
Eurex Group is owned by Deutsche Börse AG (Xetra: DB1).
Ivette Almeida, Paragon PR
+1 917 302 9946
Patrick Sutton, Paragon PR